Clinical Trials Logo

Pre-Eclampsia; Mild clinical trials

View clinical trials related to Pre-Eclampsia; Mild.

Filter by:
  • None
  • Page 1

NCT ID: NCT03323762 Completed - Clinical trials for Gestational Hypertension

Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia

Start date: October 24, 2017
Phase: N/A
Study type: Interventional

The aim of this pilot cohort study is to investigate whether treatment with remote ischemic conditioning (RIC) has a beneficial effect on blood pressure as well as the immune system in pregnant women with newly diagnosed hypertension (> 140/58 mm Hg) or pre-eclampsia before gestational week 37+3.

NCT ID: NCT03262961 Recruiting - Pre-Eclampsia; Mild Clinical Trials

Use of Sildenafil Citrate in Management of Mild Pre-eclampsia

Start date: September 15, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

- Mild pre-eclampsia represents 75% of cases with pre-eclampsia, possible progression to severe pre-eclampsia makes mild pre-eclampsia a serious problem that requires attention. - Previous studies have shown that expectant and conservative management of pre-eclampsia in the context of extreme prematurity may improve perinatal outcomes. Indeed, it has been estimated that for each additional day of pregnancy prolongation between 24 and 32 weeks of gestation, there is a nonlinear corresponding gain of 1% in fetal survival. - Sildenafil citrate has been used for increasing utero-placental perfusion in cases with intrauterine growth restriction, which makes it a promising drug in management of mild pre-eclampsia.